Dynavax Technologies Corporation (DVAX) financial statements (2022 and earlier)

Company profile

Business Address 2100 POWELL STREET
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:54616515114619281196
Cash and cash equivalents436324049272445
Short-term investments1101331119616557151
Other undisclosed cash, cash equivalents, and short-term investments0(0)0(0)0(0)(0)
Receivables      1
Inventory, net of allowances, customer advances and progress billings616441190  
Inventory616441190  
Intangible current assets    1  
Other undisclosed current assets365611610582
Total current assets:97329020917419890200
Noncurrent Assets
Operating lease, right-of-use asset262730
Property, plant and equipment35313217171714
Intangible assets, net (including goodwill)22514222
Goodwill2222222
Intangible assets, net (excluding goodwill)  312   
Restricted cash and investments0001111
Other noncurrent assets3435100
Total noncurrent assets:67637037212017
TOTAL ASSETS:1,039353279211219110217
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities65313129141925
Accounts payable3395543
Accrued liabilities50191516101115
Employee-related liabilities13978 46
Deferred revenue55  
Debt  3    
Restructuring reserve  1    
Deferred revenue and credits  3
Other liabilities33107   
Other undisclosed current liabilities4334392411
Total current liabilities:556775338192029
Noncurrent Liabilities
Long-term debt and lease obligation34215216101   
Long-term debt, excluding current maturities 180179101   
Operating lease, liability343538
Liabilities, other than long-term debt6319101
Other liabilities6319101
Other undisclosed noncurrent liabilities220      
Total noncurrent liabilities:260217218110101
Total liabilities:817295271148192030
Stockholders' equity
Stockholders' equity attributable to parent2225986320089187
Common stock0000000
Additional paid in capital1,4421,3521,2291,1311,108905890
Accumulated other comprehensive income (loss)(2)0(2)(2)(1)(4)(3)
Accumulated deficit(1,217)(1,294)(1,219)(1,066)(907)(812)(700)
Total stockholders' equity:2225986320089187
TOTAL LIABILITIES AND EQUITY:1,039353279211219110217

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues439473580114
Revenue, net0114
Sublease income 83
Cost of revenue(174)(3)(10)(11)   
Cost of goods and services sold(174)(3)(9)(11)   
Gross profit:2664425(3)0114
Operating expenses(132)(112)(160)(162)(96)(122)(109)
Other undisclosed operating income1  11   
Operating income (loss):134(68)(135)(153)(96)(111)(105)
Nonoperating income (expense)10441(2)0
Investment income, nonoperating0134110
Loss on sale of leased assets, net, operating leases     (0)(1)
Other nonoperating income (expense)1(1)1(0)(0)(2)0
Interest and debt expense(16)(19)(17)(9)  (2)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (5)  01
Income (loss) from continuing operations before equity method investments, income taxes:119(87)(153)(159)(95)(112)(107)
Other undisclosed loss from continuing operations before income taxes(42)      
Income (loss) from continuing operations before income taxes:78(87)(153)(159)(95)(112)(107)
Income tax expense(1)      
Net income (loss):77(87)(153)(159)(95)(112)(107)
Other undisclosed net income attributable to parent 12     
Net income (loss) attributable to parent:77(75)(153)(159)(95)(112)(107)
Preferred stock dividends and other adjustments  (3)    
Undistributed earnings (loss) allocated to participating securities, basic5    
Other undisclosed net loss available to common stockholders, basic(9)      
Net income (loss) available to common stockholders, basic:72(75)(156)(159)(95)(112)(107)
Other undisclosed net income (loss) available to common stockholders, diluted4(4)     
Net income (loss) available to common stockholders, diluted:76(79)(156)(159)(95)(112)(107)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):77(87)(153)(159)(95)(112)(107)
Other comprehensive income (loss)(3)3(0)(1)3(1)(1)
Comprehensive income (loss):74(84)(153)(160)(92)(113)(108)
Other undisclosed comprehensive income, net of tax, attributable to parent 12     
Comprehensive income (loss), net of tax, attributable to parent:74(73)(153)(160)(92)(113)(108)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: